Jesse Steffens

Dendrimer-RNA nanoparticles generate protective immunity against lethal Ebola, H1N1 influenza, and Toxoplasma gondii challenges with a single dose

Lipid-nanoparticle-encapsulated mRNA vaccines induce protective memory CD8 T cells against a lethal viral infection

Dendritic cells in cancer immunology and immunotherapy

Messenger RNA-Based Vaccines Against Infectious Diseases

Can Ebola Virus Vaccines Have Universal Immune Correlates of protection?

mRNA vaccines — a new era in vaccinology

Lipid nanoparticles for mRNA delivery

Vaccination with Messenger RNA: A Promising Alternative to DNA Vaccination

Recent advances in mRNA vaccine technology

mRNA vaccines for infectious diseases: principles, delivery and clinical translation

A Multi-Targeting, Nucleoside-Modified mRNA Influenza Virus Vaccine Provides Broad Protection in Mice

Delivery technologies for cancer immunotherapy

Nucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies

Viral Emerging Diseases: Challenges in Developing Vaccination Strategies

Nanomaterial Delivery Systems for mRNA Vaccines

Organic and inorganic nanoparticle vaccines for prevention of infectious diseases

One-Component Multifunctional Sequence-Defined Ionizable Amphiphilic Janus Dendrimer Delivery Systems for mRNA

Targeted Delivery of mRNA with One-Component Ionizable Amphiphilic Janus Dendrimers

Vaccine adjuvant uses of poly-IC and derivatives

Chemically Modified Bacterial Sacculi as a Vaccine Microparticle Scaffold

Cross-Protection Conferred by Filovirus Virus-Like Particles Containing Trimeric Hybrid Glycoprotein

Toll-Like Receptor Agonist Augments Virus-Like Particle-Mediated Protection from Ebola Virus with Transient Immune Activation

T-cell-dependent mechanisms promote Ebola VLP-induced antibody responses, but are dispensable for vaccine-mediated protection

Multilamellar Vaccine Particle Elicits Potent Immune Activation with Protein Antigens and Protects Mice against Ebola Virus Infection